SEC Tracker
Get the app

TELA Bio TELA

OrbiMed Private Investments IV (Shareholder) plans to sell 192,000 TELA shares, about $2M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Apr 19, 2023
  2. Broker: Themis Trading LLC
  3. Shares acquired by: Private placement

All of OrbiMed Private Investments IV's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 136,000 shares at $9.3 on Apr 19, 2023 · Form 4
  • Sold 28,300 shares at $9.43 on Apr 20, 2023 · Form 4
  • Sold 27,700 shares at $9.41 on Apr 21, 2023 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when TELA Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. enVVeno Medical NVNO public float $76M, Jun 30, 2025
  2. Carlsmed CARL
  3. Apyx Medical APYX public float $80M, Jun 30, 2025
  4. Spectral AI MDAI public float $72M, Jun 30, 2025
  5. Lucid Diagnostics LUCD public float $83M, Jun 30, 2025